Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AZTherapies

AZTherapies
2011 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$19M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of pharmaceutical drugs designed to provide treatment for multiple neurodegeneration and neuroinflammation-related CNS diseases. The company's products include ALZT-OP1 is a novel multi-action combination drug regimen which is use to modify disease progression by slowing down or halting Alzheimer's disease early in its development, enabling healthcare providers to cure Alzheimer's patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 200 Clarendon Street
  • 17th Floor
  • Boston, MA 02116
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AZTherapies’s full profile, request a free trial.

AZTherapies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 12-Jul-2019 $19M 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 16-Oct-2018 000.00 000.00 00000 Completed Generating Revenue
3. Later Stage VC 0000 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 06-Feb-2017 $16.4M $26.4M 00000 Completed Generating Revenue
1. Early Stage VC 06-Jan-2015 $10M $10M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

AZTherapies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-2 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series A-1 2,084,052 $0.000100 $3.33 $3.33 1x $3.33 4.58%
Series A 4,212,559 $0.000100 $4 $4 1x $4 9.26%
To view this company’s complete Cap Table, request access »

AZTherapies Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cadent Therapeutics Venture Capital-Backed Cambridge, MA 0 000.00 00000000000 000.00
0000 Venture Capital-Backed San Diego, CA 00 00.000 00000 00000
000000000 00000000 Venture Capital-Backed Cambridge, MA 00 000.00 0&0
000000 00000000000 Venture Capital-Backed San Diego, CA 000.00 00000000000 000.00
00000000 000000000 Venture Capital-Backed Cambridge, MA 00 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

AZTherapies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
DRADS Holdings Venture Capital Minority 000 0000 000000 0
Dolby Family Ventures Venture Capital Minority 000 0000 000000 0

AZTherapies Executive Team (8)

Name Title Board
Seat
Contact
Info
David Elmaleh Ph.D Founder, Chairman & Chief Executive Officer
Karen Reeves MD President & Chief Medical Officer
Robert Warren JD Chief Operating Officer & Chief Financial Officer
Jay Mohr Chief Operating & Business Officer and Head of Commercial Development
Keith Greenfield Board Member & Executive Vice President, Business Development

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »

AZTherapies Board Members (8)

Name Representing Role Since Contact
Info
David Elmaleh Ph.D AZTherapies Founder, Chairman & Chief Executive Officer 000 0000
David Taft Self Board Member 000 0000
George Behrakis AZTherapies Board Member 000 0000
Gillian Sandler Self Board Member 000 0000
John Porter AZTherapies Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »